EXAS Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 156 min ago

@ $61.95

Wydano: 3 geg. 2024 @ 20:15

Zwrot: 0.36%

Poprzedni sygnał: geg. 3 - 16:30

Poprzedni sygnał: Sprzedaż

Zwrot: -0.63 %

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 22:52):

Stats
Dzisiejszy wolumen	1.29M
Średni wolumen	2.48M
Kapitalizacja rynkowa	11.43B
EPS	$0 ( 2024-02-21 )
Następna data zysków	( $-0.500 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-55.02
ATR14	$2.53 (4.06%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-30	Coward D Scott	Buy	218	Common Stock
2024-05-01	Coward D Scott	Sell	67	Common Stock
2024-04-30	Cunningham Everett	Buy	708	Common Stock
2024-05-01	Cunningham Everett	Sell	136	Common Stock
2024-04-30	Cunningham Everett	Buy	291	Common Stock

INSIDER POWER
40.73
Last 100 transactions
Buy: 527 629 \| Sell: 221 684

Wolumen Korelacja

Długi: -0.64 (weak negative)

Krótki: 0.44 (neutral)

Signal:(55) Neutral

Exact Sciences Corp Korelacja

10 Najbardziej pozytywne korelacje
AVEO	0.942
ITMR	0.941
HZNP	0.928
LUNA	0.926
WLFC	0.925
MLCO	0.923
FCBP	0.922
NWLI	0.92
OBAS	0.916
NWFL	0.914

10 Najbardziej negatywne korelacje
GOSS	-0.97
VS	-0.951
XFOR	-0.95
GROM	-0.938
TOPS	-0.933
USEG	-0.932
QTEK	-0.931
TRVN	-0.931
SG	-0.93
THTX	-0.929

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Exact Sciences Corp Korelacja - Waluta/Towar

-0.31
( neutral )

-0.70
( moderate negative )

0.00
( neutral )

-0.21
( neutral )

-0.36
( neutral )

0.52
( weak )

Exact Sciences Corp Finanse

Annual	2023
Przychody:	$2.50B
Zysk brutto:	$1.85B (73.83 %)
EPS:	$-1.130

FY	2023
Przychody:	$2.50B
Zysk brutto:	$1.85B (73.83 %)
EPS:	$-1.130

FY	2022
Przychody:	$2.08B
Zysk brutto:	$1.51B (72.44 %)
EPS:	$-3.54

FY	2021
Przychody:	$1.77B
Zysk brutto:	$1.31B (74.04 %)
EPS:	$-3.48

Financial Reports:

No articles found.

Exact Sciences Corp

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; Oncomap ExTra, that provides a complete biological picture of certain refractory, rare, or aggressive cancers; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

Aktualne aktualizacje dla Exact Sciences Corp [EXAS]

Upcoming Earnings Alert